Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Segezha Group launched production of fuel briquettes in Ust-Kut

11/6/24 SGZH

O'Key's revenue for 9 months grew by 5.6%

11/6/24 OKEY

Ozon reported for 9 months of 2024

11/6/24 OZON

Ozon's turnover for 9 months of 2024 increased by 71%

11/6/24 OZON

SFI management proposed to raise dividend based for 9 months of 2024

11/6/24 SFIN

Vadim Badekha appointed UAC CEO

11/6/24 UNAC

Lukoil to sell refinery in Bulgaria by the end of the year

11/6/24 LKOH

Board of Directors of Novorossiysk Bakery Products Plant recommended dividends

11/5/24 NKHP

Mostotrest reports for 9 months of 2024 by RAS

11/5/24 MSTT

Yuzhuralzoloto reported for 9 months of 2024 by RAS

11/5/24 UGLD